Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
ACS Chemical Neuroscience|April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding ProbeRobert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.Journal of Medicinal Chemistry|December 4, 2003
Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitorsSubhash P Khanapure, David S Garvey, Delano V Young, et al.Journal of Medicinal Chemistry|May 27, 2005
3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluationSubhash P Khanapure, Michael E Augustyniak, Richard A Earl, et al.Biochemical Pharmacology|September 20, 2005
A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methodsDelano V Young, Edward D Cochran, Vijay Dhawan, et al.Journal of Medicinal Chemistry|April 16, 2004
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazolesRamani R Ranatunge, Michael Augustyniak, Upul K Bandarage, et al.Journal of Medicinal Chemistry|April 7, 2021
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma EfficacySumanta Garai, Luciana M Leo, Anna-Maria Szczesniak, et al.Inflammopharmacology|November 2, 2005
NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donorJames L Ellis, Michael E Augustyniak, Edward D Cochran, et al.Journal of Medicinal Chemistry|November 13, 2007
Structure-based design, synthesis, and biological evaluation of indomethacin derivatives as cyclooxygenase-2 inhibiting nitric oxide donorsShiow-Jyi Wey, Michael E Augustyniak, Edward D Cochran, et al.Journal of Medicinal Chemistry|November 23, 2019
Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric ModulatorsSumanta Garai, Pushkar M Kulkarni, Peter C Schaffer, et al.Pageof 7